Results 211 to 220 of about 66,239 (358)
This case describes a 55‐year‐old female with stage IIIA RET fusion‐positive lung adenocarcinoma and thromboembolic contraindications who achieved significant tumour downstaging after neoadjuvant selpercatinib therapy, enabling successful curative resection.
Zihan Cui +4 more
wiley +1 more source
A Societal Perspective Cost-Utility Analysis of Rivaroxaban Compared with Enoxaparin Sodium in Patients Undergoing Total Hip or Total Knee Replacement Surgery [PDF]
Björn Stollenwerk +5 more
openalex +1 more source
Contraception in Myeloproliferative Neoplasms: A Pharmacological Review
ABSTRACT Myeloproliferative neoplasms (MPNs) are chronic hematologic disorders characterized by clonal proliferation of myeloid lineage cells, commonly driven by JAK2 mutations, and associated with significant thrombotic and hemorrhagic complications.
Awni Alshurafa +4 more
wiley +1 more source
ABSTRACT Background We present the case of a kidney transplant recipient with elevated serum creatinine who developed left upper limb swelling due to left subclavian vein thrombosis. Concerned about potential hemodialysis resumption, the patient prioritized preserving their arteriovenous fistula.
Limei Chen, Ruining Liu, Tianlei Cui
wiley +1 more source
The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty [PDF]
Robert D. Russell +3 more
openalex +1 more source
ABSTRACT Background Vascular recovery from catheter ablation (CA) has traditionally required a period of leg immobilization which can lead to discomfort and prolonged time to discharge. Objective The objective of this study was to compare a strategy of immediate leg mobilization (IM) using suture‐mediated closure devices against traditional vascular ...
Riya Sam +8 more
wiley +1 more source
RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms [PDF]
Mustafa Çelebi̇er +3 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 5, Page 3771-3775, October 2025.
Simone Sarzilla +4 more
wiley +1 more source

